Semaglutide for Low Back Pain

NCT07731256 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Lower Back Pain
Obesity (BMI>30)
Chronic Lower Back Pain
glp1 Agonist

Interventions

DRUG: Semaglutide (administered by PDS290 pen-injector)
DRUG: Placebo (administered by PDS290 pen-injector)

Sponsor

Washington University School of Medicine

Collaborators

[object Object]